Patent details
EP3202779
Title:
LONG-ACTING HGH POLYPEPTIDES AND USES THEREOF
Basic Information
- Publication number:
- EP3202779
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP171611999
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- LONG-ACTING HGH POLYPEPTIDES AND USES THEREOF
- French Title of Invention:
- Polypeptides à action prolongée et procédés de production et d'administration associés
- German Title of Invention:
- Polypeptide mit langzeitwirkung sowie Verfahren zu ihrer Herstellung und Verabreichung
- SPC Number:
-
Dates
- Filing date:
- 05/02/2007
- Grant date:
- 04/12/2019
- EP Publication Date:
- 09/08/2017
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/12/2019
- EP B1 Publication Date:
- 04/12/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 05/02/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/11/2019
-
-
- Name:
- OPKO Biologics Ltd.
- Address:
- 16 Ashlegan Street, Kiryat Gat, 8211804, Israel (IL)
Agent
- Name:
- MURGITROYD & COMPANY
- From:
- 05/03/2020
- Address:
- SCOTLAND HOUSE, SCOTLAND STREET 165-169, G5 8PL, GLASGOW / SCOTLAND, United Kingdom (GB)
- To:
Inventor
1
- Name:
- Fima, Udi Eyal
- Address:
- Israel (IL)
2
- Name:
- Fares, Fuad
- Address:
- Israel (IL)
Priority
- Priority Number:
- 764761 P
- Priority Date:
- 03/02/2006
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/00;
A61K 38/00;
A61K 38/19;
A61K 38/24;
C07K 14/00;
C07K 14/505;
C07K 14/52;
C07K 14/575;
C07K 14/61;
C12N 5/00;
C12N 15/00;
Publication
European Patent Bulletin
- Issue number:
- 201949
- Publication date:
- 04/12/2019
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 02/03/2026
- Annual Fee Number:
- 20
- Annual Fee Amount:
- 300 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 10/01/2025
- Last Annual Fee Paid Number:
- 19
- Last Annual Fee Paid Amount:
- 281 Euro
- Payer:
- MASTER DATA CENTER INC (ex Clarivate Analytics)